The Pennant Group (PNTG) vs. Its Peers Critical Survey

The Pennant Group (NASDAQ:PNTG – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare The Pennant Group to similar businesses based on the strength of its profitability, institutional ownership, dividends, valuation, earnings, analyst recommendations and risk.

Institutional & Insider Ownership

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 6.9% of The Pennant Group shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility and Risk

The Pennant Group has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, The Pennant Group’s rivals have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for The Pennant Group and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group 0 1 6 0 2.86
The Pennant Group Competitors 1879 7752 13385 833 2.55

The Pennant Group presently has a consensus target price of $48.00, suggesting a potential upside of 33.07%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.38%. Given The Pennant Group’s stronger consensus rating and higher possible upside, analysts plainly believe The Pennant Group is more favorable than its rivals.

Profitability

This table compares The Pennant Group and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
The Pennant Group 3.05% 10.23% 4.06%
The Pennant Group Competitors -7.87% -135.89% -1.58%

Earnings & Valuation

This table compares The Pennant Group and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
The Pennant Group $947.71 million $29.58 million 36.43
The Pennant Group Competitors $19.11 billion $301.67 million -1.70

The Pennant Group’s rivals have higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

The Pennant Group beats its rivals on 9 of the 13 factors compared.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc. provides healthcare and senior living services through independently operated subsidiaries. Its services include home health and hospice care for people in their homes, as well as senior living options such as assisted living and memory care. Based in Eagle, Idaho, the company operates across multiple U.S. states, with a presence concentrated in the western part of the country. Its local operating teams provide care and support to patients, residents and their families. Pennant became an independent publicly traded company in 2019 after separating from The Ensign Group.

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.